A Sugar-Sweetened Beverage Reduction Intervention for Native American Men
| 대상 질환 | Cardiovascular Disorder, Coronary Artery Disease, Diabetes Mellitus, Obesity-Related Malignant Neoplasm |
|---|---|
| 임상 단계 | 단계 해당 없음 |
| 스폰서 | Roswell Park Cancer Institute |
| 상태 | 완료 |
| 참여자 수 | 48 명 |
| 중재(약물) | Education Intervention, Observation of Indigenous SIPin Interventon, Discussion |
| 시작일 | 2022년 7월 20일 |
| 완료일 | 2025년 9월 15일 |
| 결과 공개일 | 2026년 7월 28일 |
요약
This clinical trial develops and tests a culturally-appropriate educational program (Indigenous SIPin) for reducing sugar-sweetened beverage consumption in men affiliated with Native American athletics communities. Sugary drinks are drinks like pop, soda, and juice. Increased sugar consumption may lead to an increased risk of chronic diseases, including obesity, diabetes, some types of obesity-related cancers, coronary heart disease, hypertension, and dental decay. A culturally sensitive program may help reduce sugar-sweetened beverage consumption in Native American men
Change in SSB Intake for Men Affiliated With Native American Athletic Communities
| Arm 1 - Indigenous SIPin | 0.18 ± 87.31 kcal per day |
|---|
BENITIONS에서 보기 ClinicalTrials.gov 원문 보기
같은 질환의 다른 임상
- Ignite Pilot: Goal Setting in a Digital Weight Loss Intervention — Stanford University
- Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects — University of Pennsylvania
- Cardiovascular Outcomes in Bariatric Surgery Patients With Type 2 Diabetes — The Cleveland Clinic
- Time Restricted Eating for Weight Loss Maintenance — NYU Langone Health
- Diabetes Prevention Program Outcomes Study — National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Effect of PDE5 Inhibition on Adipose Metabolism in Humans — Vanderbilt University Medical Center